Geode Capital Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Geode Capital Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-1,142,444	Closed	-$77.8M	–	5075
2022 Q3	$77.8M	Buy	1,142,444 +58,608	+5%	+$3.99M	0.01%	796
2022 Q2	$34.6M	Sell	1,083,836 -2,788	-0.3%	-$89.1K	0.01%	1367
2022 Q1	$37.6M	Buy	1,086,624 +12,589	+1%	+$436K	﹤0.01%	1451
2021 Q4	$31.4M	Buy	1,074,035 +11,430	+1%	+$335K	﹤0.01%	1660
2021 Q3	$27.1M	Sell	1,062,605 -40,358	-4%	-$1.03M	﹤0.01%	1748
2021 Q2	$38.6M	Buy	1,102,963 +333,240	+43%	+$11.7M	0.01%	1526
2021 Q1	$31.4M	Buy	769,723 +17,993	+2%	+$733K	﹤0.01%	1574
2020 Q4	$32.6M	Buy	751,730 +62,765	+9%	+$2.72M	0.01%	1403
2020 Q3	$38M	Sell	688,965 -27,069	-4%	-$1.49M	0.01%	1072
2020 Q2	$45.2M	Sell	716,034 -166,769	-19%	-$10.5M	0.01%	950
2020 Q1	$45.1M	Buy	882,803 +61,459	+7%	+$3.14M	0.01%	819
2019 Q4	$65.3M	Buy	821,344 +24,775	+3%	+$1.97M	0.01%	790
2019 Q3	$38.6M	Buy	796,569 +63,646	+9%	+$3.09M	0.01%	1031
2019 Q2	$38.6M	Buy	732,923 +55,226	+8%	+$2.9M	0.01%	1037
2019 Q1	$35.9M	Buy	677,697 +57,967	+9%	+$3.07M	0.01%	1029
2018 Q4	$25.4M	Buy	619,730 +83,347	+16%	+$3.42M	0.01%	1115
2018 Q3	$20.4M	Buy	536,383 +30,238	+6%	+$1.15M	0.01%	1404
2018 Q2	$22.9M	Buy	506,145 +86,358	+21%	+$3.9M	0.01%	1258
2018 Q1	$20.3M	Buy	419,787 +78,836	+23%	+$3.81M	0.01%	1251
2017 Q4	$13.4M	Buy	340,951 +7,875	+2%	+$310K	﹤0.01%	1534
2017 Q3	$10.3M	Buy	333,076 +45,681	+16%	+$1.42M	﹤0.01%	1697
2017 Q2	$7.86M	Buy	287,395 +42,728	+17%	+$1.17M	﹤0.01%	1830
2017 Q1	$9.02M	Buy	244,667 +91,498	+60%	+$3.37M	﹤0.01%	1689
2016 Q4	$2.21M	Buy	153,169 +18,702	+14%	+$270K	﹤0.01%	2575
2016 Q3	$3.1M	Buy	134,467 +71,752	+114%	+$1.65M	﹤0.01%	2277
2016 Q2	$1.04M	Buy	62,715 +9,282	+17%	+$154K	﹤0.01%	2885
2016 Q1	$847	Buy	53,433 +1,334	+3%	+$21	﹤0.01%	2971
2015 Q4	$1.68M	Buy	52,099 +10,748	+26%	+$347K	﹤0.01%	2585
2015 Q3	$1.74M	Buy	+41,351	New	+$1.74M	﹤0.01%	2532